Clinical Trial

IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)

Name: IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE) — clinical trial record (NCT07617740)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, open-label, exploratory clinical study designed to evaluate the efficacy and safety of IASO207 Injection (in vivo CAR-T) in patients with active refractory systemic lupus erythematosus.

Trial Details

NCT Number	NCT07617740
Lead Sponsor	Peking University People's Hospital Collaborators: Nanjing IASO Biotechnology Co., Ltd.
Conditions	REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Enrollment	18 participants
Start Date	2026-05-25
Primary Completion	2029-05-30 (estimated)
Study Completion	2030-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-01